D-0210-2026 Class II Ongoing

Recalled by Blossom Pharmaceuticals — Bardej, Goa

FDA drug recall D-0210-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 12150 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 10, 2025
Initiation Date
Oct 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12150 bottles

Product description

Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301 USA, Made in India, NDC 69396-087-01.

Reason for recall

cGMP deviations

Distribution pattern

USA Nationwide

Code information

Lot #: A472408

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0210-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0210-2026. Report a data issue: hello@regdatalab.com.